C, J., S, P., L, D., CL, S., & S, G. (2022). Clinical outcomes of de novo metastatic HER2-low breast cancer: A National Cancer Database Analysis. NPJ breast cancer, 8(1), 135. https://doi.org/10.1038/s41523-022-00498-8
Chicago Style (17th ed.) CitationC, Jiang, Perimbeti S, Deng L, Shapiro CL, and Gandhi S. "Clinical Outcomes of De Novo Metastatic HER2-low Breast Cancer: A National Cancer Database Analysis." NPJ Breast Cancer 8, no. 1 (2022): 135. https://doi.org/10.1038/s41523-022-00498-8.
MLA (9th ed.) CitationC, Jiang, et al. "Clinical Outcomes of De Novo Metastatic HER2-low Breast Cancer: A National Cancer Database Analysis." NPJ Breast Cancer, vol. 8, no. 1, 2022, p. 135, https://doi.org/10.1038/s41523-022-00498-8.
Warning: These citations may not always be 100% accurate.